The name of the CAR-T cell therapy is NexCAR19.
This disease was discussed by health experts at the World Economic Forum (WEF) meeting.
The added sugar content has been decreased by 15%.
The new variant is called JN.1.
Darcy Dunn-Lawless of the University of Oxford and his colleagues invented this technique.
WHO has set up a commission to address this issue.